Literature DB >> 6777817

The Leeds Sleep Evaluation Questionnaire in psychopharmacological investigations - a review.

A C Parrott, I Hindmarch.   

Abstract

The Leeds Sleep Evaluation Questionnaire comprises ten self-rating 100-mm-line analogue questions concerned with aspects of sleep and early morning behaviour. The questionnaire has been used to monitor subjectively perceived changes in sleep during psychopharmacological investigations involving a variety of psychoactive agents, including sedative-hypnotics, antidepressants, anxiolytics, CNS stimulants, and antihistamines. Dose-related improvements in the self-reported ratings of getting to sleep and perceived quality of sleep were generally associated with reductions in the self-reported levels of alertness and behavioural integrity the morning following the nocturnal administration of sedative hypnotic and anti-anxiety agents. Psychostimulants on the other hand, impaired subjective ratings of sleep and produced increases in early morning assessments of alertness. Certain antidepressant and antihistaminic agents produced effects similar to the sedative-hypnotics, while others did not affect self-reported aspects of sleep and early morning behaviour.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6777817     DOI: 10.1007/bf00434408

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  31 in total

1.  Measures of sleep disturbance in psychiatric patients.

Authors:  D G McDonald; E A King
Journal:  Br J Med Psychol       Date:  1975-03

2.  Effect of diazepam and fosazepam (a soluble derivative of diazepam) on sleep in man.

Authors:  A N Nicholson; B M Stone; C H Clarke
Journal:  Br J Clin Pharmacol       Date:  1976-08       Impact factor: 4.335

3.  Differences between light and sound sleepers in the residual effects of nitrazepam.

Authors:  A W Peck; C E Bye; R Claridge
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

4.  The residual effects of flurazepam.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1973-09-28

5.  Residual effects of hypnotics.

Authors:  A J Bond; M H Lader
Journal:  Psychopharmacologia       Date:  1972

6.  Sensitivity and accuracy of the visual analogue scale: a psycho-physical classroom experiment.

Authors:  C Maxwell
Journal:  Br J Clin Pharmacol       Date:  1978-07       Impact factor: 4.335

7.  A repeated dose comparison of dichloralphenazone, flunitrazepam and amylobarbitone sodium on some aspects of sleep and early morning behaviour in normal subjects.

Authors:  I Hindmarch; A C Parrott; L Arenillas
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

8.  A clinical and psychometric evaluation of flurazepam.

Authors:  M R Salkind; T Silverstone
Journal:  Br J Clin Pharmacol       Date:  1975-06       Impact factor: 4.335

9.  Persistent behavioural and electroencephalographic changes after single doses of nitrazepam and amylobarbitone sodium.

Authors:  A Malpas; A J Rowan; C R Boyce; D F Scott
Journal:  Br Med J       Date:  1970-06-27

10.  The effect of a sub-chronic administration of three dose levels of a 1,5-benzodiazepine derivative, clobazam, on subjective assessments of sleep and aspects of psychomotor performance the morning following night time medication.

Authors:  I Hindmarch; A C Parrott
Journal:  Arzneimittelforschung       Date:  1978
View more
  77 in total

Review 1.  A systematic review of patient-reported outcome instruments measuring sleep dysfunction in adults.

Authors:  Emily Beth Devine; Zafar Hakim; Jesse Green
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

2.  A double-blind, placebo-controlled investigation of the residual psychomotor and cognitive effects of zolpidem-MR in healthy elderly volunteers.

Authors:  Ian Hindmarch; Eric Legangneux; Neil Stanley; Steve Emegbo; Jean Dawson
Journal:  Br J Clin Pharmacol       Date:  2006-11       Impact factor: 4.335

Review 3.  Approaches to measuring the effects of wake-promoting drugs: a focus on cognitive function.

Authors:  Christopher J Edgar; Edward F Pace-Schott; Keith A Wesnes
Journal:  Hum Psychopharmacol       Date:  2009-07       Impact factor: 1.672

4.  Assessing pentobarbital preference in normal volunteers using a cumulative dosing procedure.

Authors:  H de Wit; J Pierri; C E Johanson
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

5.  Subjective and behavioral effects of marijuana the morning after smoking.

Authors:  L D Chait
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Thyrotropin-releasing hormone as a treatment for cancer-related fatigue: a randomized controlled study.

Authors:  Jayesh Kamath; Richard Feinn; Andrew Winokur
Journal:  Support Care Cancer       Date:  2011-09-27       Impact factor: 3.603

7.  Subjective and behavioral effects of diazepam depend on its rate of onset.

Authors:  H de Wit; S Dudish; J Ambre
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

8.  Effect of setting on the reinforcing and subjective effects of ethanol in social drinkers.

Authors:  P Doty; H de Wit
Journal:  Psychopharmacology (Berl)       Date:  1995-03       Impact factor: 4.530

9.  Nomifensine, clobazam and HOE 8476: effects on aspects of psychomotor performance and cognitive ability.

Authors:  A C Parrott; I Hindmarch; P D Stonier
Journal:  Eur J Clin Pharmacol       Date:  1982-10       Impact factor: 2.953

10.  Loprazolam (HR158) and flurazepam with ethanol compared on tests of psychomotor ability.

Authors:  I Hindmarch; A C Gudgeon
Journal:  Eur J Clin Pharmacol       Date:  1982       Impact factor: 2.953

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.